Prelude Capital Management’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-33,635
| Closed | -$203K | – | 2305 |
|
|
2019
Q4 | $203K | Buy |
+33,635
| New | +$195K | 0.01% | 855 |
|
|
2017
Q3 | – | Sell |
-2,200
| Closed | -$10K | – | 2024 |
|
|
2017
Q2 | $10K | Sell |
2,200
-6,900
| -76% | -$27.7K | ﹤0.01% | 1400 |
|
|
2017
Q1 | $38K | Buy |
+9,100
| New | +$37.8K | ﹤0.01% | 1123 |
|
|
2016
Q4 | – | Sell |
-3,000
| Closed | -$24K | – | 1902 |
|
|
2016
Q3 | $24K | Buy |
+3,000
| New | +$25.5K | ﹤0.01% | 1309 |
|
|
2013
Q4 | – | Sell |
-22,900
| Closed | -$69K | – | 2048 |
|
|
2013
Q3 | $69K | Sell |
22,900
-101,432
| -82% | -$695K | 0.01% | 883 |
|
|
2013
Q2 | $1.02M | Buy |
+124,332
| New | +$949K | 0.22% | 107 |
|